What happened, in summary

At age 30, this patient found a large lump in her left breast after noticing a brief pain. A mammogram, ultrasound and biopsy led to a Stage II breast cancer diagnosis. Because several relatives had developed cancer at young ages, she was also referred for genetic counseling and tested positive for a BRCA1 mutation.

Before chemotherapy was due to begin, she met with an oncofertility specialist because treatment could affect fertility. She completed 2 weeks of fertility medication and an egg-retrieval procedure so that eggs could be frozen for the future. The BRCA1 result then helped guide her surgical decision-making. She chose a double mastectomy to reduce the risk of recurrence and later underwent breast reconstruction, with tissue expanders replaced by implants.

The mutation also changed how she approached future cancer risk. Because BRCA1 can increase ovarian cancer risk, she planned ovarian screening every 6 months and intended to consider ovary removal after having children. Her relatives also pursued testing and preventive options.

After treatment, she described herself as a breast cancer survivor, volunteered to support other young patients and looked forward to returning to flamenco dancing, Zumba, yoga and everyday activities.